Literature DB >> 23795858

Psychotic disorder is an independent risk factor for increased fasting glucose and waist circumference.

Urban Osby1, Eric Olsson, Gunnar Edman, Agneta Hilding, Sven V Eriksson, Claes Göran Ostenson.   

Abstract

BACKGROUND: Psychosis is associated with excess cardiovascular morbidity and mortality. AIMS: To determine the prevalence of cardiovascular risk factors in patients with psychotic disorders compared with the population.
METHODS: 731 consecutive patients with psychosis recruited from psychiatric outpatient clinics in Stockholm County, Sweden, were compared with 5580 individuals from a population study performed in the same area. The main outcome measures were waist circumference, body mass index (BMI) and fasting glucose.
RESULTS: Mean waist circumference in patients vs. controls was for males 106 and 94 cm, respectively, and for females 97 and 85 cm, respectively (P < 0.001); mean fasting glucose in patients vs. controls was for males 5.8 and 5.2 mmol/l, respectively, and for females 5.6 and 4.8 mmol/l, respectively (P < 0.001). Comparisons were controlled for differences in age and family history of diabetes. Increased waist circumference was more common in psychotic patients compared with controls (OR = 3.99; 95% CI 3.09-5.15), controlling for fasting insulin, differences in gender, blood pressure, fasting glucose, family history of diabetes, age and tobacco use. Increased fasting blood glucose was also more common in psychotic patients (OR = 2.41; 95% CI 1.84-3.14) controlling for the same factors with the exception of fasting glucose and with the addition of increased waist circumference.
CONCLUSION: Our study shows that the psychosis illness per se can be considered as a cardiovascular risk factor, independent of the traditional risk factors such as age and smoking.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23795858     DOI: 10.3109/08039488.2013.797022

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  5 in total

1.  Genetic and Clinical Factors Affecting Plasma Clozapine Concentration.

Authors:  Eric Olsson; Gunnar Edman; Leif Bertilsson; Dzana Sudic Hukic; Catharina Lavebratt; Sven V Eriksson; Urban Ösby
Journal:  Prim Care Companion CNS Disord       Date:  2015-02-19

2.  Diabetes and glucose disturbances in patients with psychosis in Sweden.

Authors:  Eric Olsson; Jeanette Westman; Dzana Sudic Hukic; Sven V Eriksson; Gunnar Edman; Robert Bodén; Erik Jedenius; Johan Reutfors; Anders Berntsson; Agneta Hilding; Martin Schalling; Claes-Göran Östenson; Urban Ösby
Journal:  BMJ Open Diabetes Res Care       Date:  2015-10-09

3.  Genetic variants of increased waist circumference in psychosis.

Authors:  Dzana S Hukic; Urban Ösby; Eric Olsson; Agneta Hilding; Claes-Göran Östenson; Harvest F Gu; Ewa Ehrenborg; Gunnar Edman; Martin Schalling; Catharina Lavebratt; Louise Frisén
Journal:  Psychiatr Genet       Date:  2017-12       Impact factor: 2.458

4.  Plasma GDF15 level is elevated in psychosis and inversely correlated with severity.

Authors:  Parvin Kumar; Vincent Millischer; J Carlos Villaescusa; Ida A K Nilsson; Claes-Göran Östenson; Martin Schalling; Urban Ösby; Catharina Lavebratt
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

5.  Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study.

Authors:  Ruth Cunningham; Katrina Poppe; Debbie Peterson; Susanna Every-Palmer; Ian Soosay; Rod Jackson
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.